Our carefully selected peptide therapies including NAD+, BPC-157, GHK-Cu, and Cagrilintide are designed to enhance cellular function, accelerate healing, improve recovery, and optimize overall performance
Mice expressing dominant-negative N-cadherin develop phenotype similar to IBD This study possibly provided the first experimental in vivo evidence that manipulating mucosal epithelial cell-to-cell adhesion can modulate mucosal barrier properties and that it promotes inflammation
Comparative eects of prolonged and intermittent stimulation of the glucagon- like peptide 1 receptor on gastric emptying and glycemia
Employer clients will receive detailed updates in the coming days Member notifications will follow this fall, in line with regulatory requirements For questions, please reach out to Colbie D
PubMed Ho, E.N., Kwok, W.H., Lau, M.Y., Wong, A.S., Wan, T.S., Lam, K.K., Schiff, P.J., Stewart, B.D